Exhibit 5.3
| | | | |
| | A&L Goodbody Solicitors | | Dublin |
| International Financial Services Centre | | Belfast |
| 25-28 North Wall Quay, Dublin 1 | | London |
| D01 H104 | | New York |
| T +353 1 649 2000 | | San Francisco |
| Dx: 29 Dublin | www.algoodbody.com | | Palo Alto |
| | | | |
Date | | 6 August 2020 | | |
| | |
Our Ref | | 01416740 | | |
Iterum Therapeutics International Limited
Block 2 Floor 3, Harcourt Centre
Harcourt Street
Dublin 2
Ireland
Iterum Therapeutics plc—6.50% Exchangeable Senior Subordinated Notes due 2025 and Royalty-Linked Subordinated Notes of Iterum Therapeutics Bermuda Limited, each to be guaranteed by, amongst others, Iterum Therapeutics International Limited
Dear Sirs
We are acting as Irish counsel to Iterum Therapeutics International Limited, a private limited company incorporated under the laws of Ireland (registered number: 564304) (the Company) in connection with the filing of a registration statement (including any amendments thereto, the Registration Statement) on Form S-1 by the Company, the Company’s parent, Iterum Therapeutics plc, a public limited company incorporated under the laws of Ireland (registered number 563531) (ITP), Iterum Therapeutics Bermuda Limited, a company formed under the laws of Bermuda (the Issuer), Iterum Therapeutics US Limited, a company formed under the laws of Delaware (ITUL), and Iterum Therapeutics US Holding Limited, a company formed under the laws of Delaware (ITUH), with the United States Securities and Exchange Commission (the SEC) under the Securities Act of 1933, as amended (the Securities Act).
Pursuant to the Registration Statement, we understand that the Issuer and ITP will register the offering, issuance and sale by the Issuer of 8,400 units pursuant to non-transferable subscription rights (the Subscription Rights) granted to ITP’s shareholders and eligible warrant holders, and each unit will consist of:
| i. | a $1,000 principal amount 6.500% Exchangeable Subordinated Senior Note due 2025 (the Exchangeable Notes), which Exchangeable Notes in certain circumstances and subject to their terms may be exchanged and if exchanged may be settled, including payment of interest thereon, in cash, ordinary shares of ITP, nominal value $0.01 per share (the Exchange Shares), or a combination of cash and Exchange Shares; and |
| ii. | 50 limited recourse Royalty-Linked Subordinated Notes (the Royalty-Linked Notes, and together with the Exchangeable Notes, the Notes). |
The Exchangeable Notes will be issued as additional notes under an indenture, dated as of January 21, 2020, entered into among the Issuer, as issuer, the Company, ITP, ITUL and ITUH, as guarantors (together the Guarantors), and U.S. Bank National Association, as trustee (the EN Indenture). The Royalty-Linked Notes will be issued as additional notes under an indenture, dated as of January 21, 2020, entered into among the Issuer, the Guarantors, Iterum Holders’ Representative LLC, as holders’ representative and Computershare Trust Company, N.A., as trustee (the RLN Indenture, and together with the EN Indenture, the Indentures). We understand that the Issuer’s obligations under the Notes will be fully and unconditionally guaranteed on an unsecured senior subordinated basis by the Guarantors (the Guarantees).
PM Law • CE Gill • JG Grennan • J Coman • PD White • VJ Power • LA Kennedy • SM Doggett • B McDermott • C Duffy • PV Maher • S O’Riordan • MP McKenna • KA Feeney • M Sherlock EP Conlon • E MacNeill • KP Allen • EA Roberts • C Rogers • G O’Toole • JN Kelly • N O’Sullivan • MJ Ward • AC Burke • D Widger • C Christle • S O’Croinin • JW Yarr • DR Baxter A McCarthy • JF Whelan • JB Somerville • MF Barr • AM Curran • A Roberts • M Dale • RM Moore • D Main • J Cahir • M Traynor • PM Murray • P Walker • K Furlong • PT Fahy • D Inverarity M Coghlan • DR Francis • A Casey • B Hosty • M O’Brien • L Mulleady • K Ryan • E Hurley • G Stanley • D Dagostino • R Grey • R Lyons • J Sheehy • C Morrissey C Carroll • SE Carson • P Diggin • J Williams • A O’Beirne • MD Cole • G Conheady • J Dallas • SM Lynch • M McElhinney • C Owens • AD Ion • K O’Connor • JH Milne • T Casey • M Doyle CJ Comerford • R Marron • D Berkery • K O’Shaughnessy • S O’Connor • SE Murphy • D Nangle • L Butler • A Lawler • C Ó Conluain • N McMahon • HP Brandt • A Sheridan
Consultants: SW Haughey • Professor JCW Wylie • AF Browne • MA Greene • AV Fanagan